Hepatitis B Journal Articles

• Real-world Use of Elbasvir-Grazoprevir in Chronic HCV This retrospective analysis evaluated outcomes of hepatitis C patients treated with elbasvir-grazoprevir with or without ribavirin in clinical practice settings in the United States.
  Alimentary Pharmacology & Therapeutics, July 2018
• Twenty-Five Years of Lamivudine After 25 years, lamivudine continues to be recommended as part of ART regimens for HIV.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, June 2018
• Improving Linkage to Care Among Non-US Born Persons With HBV Seventy percent of persons in the US with chronic hepatitis B virus are non-US born. How well are we doing with providing hepatitis B testing and linkage-to-care programs to this population?
  Morbidity & Mortality Weekly Report, June 2018
• Incidence and Outcomes of Pregnancy-associated HBV Flares This study investigated the course of chronic HBV infection among pregnant women. What is the incidence of HBV flare during pregnancy and after delivery?
  Liver International, June 2018
• Liver Stiffness, Steatosis in HCV Patients With SVR on DAAs This study evaluated changes in liver stiffness and steatosis in patients with HCV who received direct-acting anti-viral therapy and achieved sustained virological response.
  Alimentary Pharmacology & Therapeutics, May 2018
• Estimating HCV Prognosis Using Transient Elastography Is non-invasive transient elastography as accurate as histologic assessment of fibrosis progression rates in estimating prognosis in treatment-naive chronic hepatitis C patients?
  Journal of Viral Hepatitis, May 2018
• Imatinib-induced Fulminant Liver Failure in CML Acute liver failure can be a fatal adverse effect of chronic myeloid leukemia treatment with imatinib. Is liver transplant a viable option for these patients?
  Journal of Medical Case Reports, May 2018
• Trends in HCC Incidence and Survival Among People With HCV This study assessed trends in HCC diagnosis rates, contribution of risk factors to HCC diagnosis, and survival after HCC diagnosis among people with HCV infection.
  Journal of Viral Hepatitis, May 2018
• EBR +/- GZR +/- Ribavirin in HCV Genotype 2, 4, 5 or 6 Patients with non-genotype 1 HCV infection differ with regard to response to DAAs. This study evaluated the efficacy and safety of EBR/GZR, with or without RBV, in HCV genotype 2, 4, 5, or 6 infection.
  Journal of Viral Hepatitis, May 2018
• Recommendations for Use of a HBV Vaccine With a Novel Adjuvant This brief report offers guidance on use of a new option for HBV prevention, Heplisav-B, a yeast-derived vaccine prepared with a novel adjuvant.
  Morbidity & Mortality Weekly Report, May 2018
• Long-term Safety of Oral Anti-virals for Chronic HBV What does the latest evidence tell us about the long-term safety profiles of nucleoside analogues for chronic hepatitis B?
  Alimentary Pharmacology & Therapeutics, May 2018
• Telbivudine to Prevent Mother-to-Child Transmission of HBV Does telbivudine in women with positive HBeAg prevent HBV transmission to the fetus--and is it safe to use in the third trimester?
  Journal of Viral Hepatitis, April 2018
• OBV/PTV/r+DSV+RBV in Patients With HCV Cirrhosis Does real-life data confirm the results of clinical trials regarding the efficacy and safety profile of this DAA regimen in patients with HCV infection and cirrhosis?
  Liver International, April 2018
• QoL in Adolescents With HCV Treated With Sofosbuvir+Ribavirin How does treatment with DAAs and viral eradication affect health-related quality of life in adolescent patients with HCV?
  Journal of Viral Hepatitis, April 2018
• Liver Transplant in Patients With Alcoholic Liver Disease Some transplant centers are reluctant to perform liver transplants in patients with alcoholic liver disease. Do these patients have worse outcomes than those transplanted for viral cirrhosis?
  Alcohol and Alcoholism, April 2018
• The Benefits of Hepatitis C Virus Cure: Every Rose Has Thorns This review examines not only the health benefits to the individual but also the associated public health benefits that come with HCV cure via DAAs.
  Journal of Viral Hepatitis, April 2018
• Exercise to Prevent Cirrhosis in Overweight and Obese Adults Learn more about the preventive role of exercise against the development of cirrhosis among overweight or obese adults.
  Liver International, April 2018
• IFN-free Chronic HCV Therapy With DAAs and Risk for HCC Does IFN-free therapy with direct-acting antivirals alter the short-term risk for hepatocellular carcinoma in patients with cirrhosis?
  Alimentary Pharmacology & Therapeutics, April 2018
• Liver Stiffness Measurement-Based Approach for HBV Decline of liver stiffness from baseline after 1 year of antiviral therapy for HBV infection may reflect remission of liver inflammation and fibrosis.
  Journal of Viral Hepatitis, April 2018
• Increase in Acute HBV -- Pasco County, Florida, 2011-2016 Surveillance data showed a sharp increase in the number of HBV infections in Pasco County, Florida in recent years.
  Morbidity & Mortality Weekly Report, March 2018